CONTINUECARE HOSPITAL MADISONVILLE
1. Target Overview & Investment Thesis
CONTINUECARE HOSPITAL MADISONVILLE is a 35-bed suburban community hospital in HOPKINS, KY with $7.7M in net patient revenue and a -2.3% operating margin. The hospital serves a payer mix of 40.7% Medicare, 5.9% Medicaid, and 53.4% commercial.
Thesis: Turnaround. Our ML models identify $576K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.3% to 5.2% (+747bps).
| Net Revenue HCRIS | $7.7M |
| Current EBITDA COMPUTED | $-177K |
| Operating Margin COMPUTED | -2.3% |
| Occupancy HCRIS | 35.6% |
| Revenue / Bed COMPUTED | $220K |
| Net-to-Gross HCRIS | 27.2% |
| Distress Probability ML | 53.4% |
2. Market Context & Competitive Position
KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -2.3% places it below the state median. Among 60 size-comparable peers (18-70 beds), the median margin is -2.2%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (18-70), prioritizing same-state peers. 60 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CONTINUECARE HOSPITAL MADISONV (Target) | KY | 35 | $7.7M | -2.3% |
| BAPTIST HEALTH LAGRANGE | KY | 42 | $236.9M | 2.7% |
| CLARK REGIONAL MEDICAL CENTER | KY | 54 | $156.4M | 16.5% |
| BAPTIST HEALTH RICHMOND | KY | 53 | $145.6M | -3.7% |
| HIGHLANDS REGIONAL MEDICAL CEN | KY | 63 | $96.5M | -32.6% |
| FLAGET MEMORIAL HOSPITAL | KY | 40 | $86.2M | -0.6% |
| ROCKCASTLE HOSPT. & RESPIR CAR | KY | 30 | $79.1M | 2.2% |
| ADVENTHEALTH MANCHESTER | KY | 49 | $73.0M | -11.0% |
| HARLAN ARH | KY | 56 | $69.9M | -24.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $576K (747bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $162K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $157K | +203bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $154K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $94K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +12bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-177K |
| + RCM Uplift | +$576K |
| Pro Forma EBITDA | $399K |
| Current Margin | -2.3% |
| Pro Forma Margin | 5.2% |
| WC Released (1x) | $295K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-272K | $4.6M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-272K | $5.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-245K | $6.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-245K | $7.3M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-299K | $1.8M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-299K | $1.9M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 53.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 60 hospitals with 18-70 beds
- Same-state prioritization (n=61)
- Comp margins: P25=-11.3% / P50=-2.2% / P75=7.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.